Clinical study of Gene‐Eden‐VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases

Hanan Polansky, Edan Itzkovitz, Adrian Javaherian

Open source

DOI
10.1186/s40169-016-0121-6
Published
2016-10-20
Container
Clinical and Translational Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

limited evidence Score 46/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40169-016-0121-6,
  title = {Clinical study of Gene‐Eden‐VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases},
  author = {Hanan Polansky and Edan Itzkovitz and Adrian Javaherian},
  year = {2016},
  journal = {Clinical and Translational Medicine},
  doi = {10.1186/s40169-016-0121-6},
  url = {https://doi.org/10.1186/s40169-016-0121-6}
}

RIS

TY  - JOUR
TI  - Clinical study of Gene‐Eden‐VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
AU  - Hanan Polansky
AU  - Edan Itzkovitz
AU  - Adrian Javaherian
PY  - 2016
JO  - Clinical and Translational Medicine
DO  - 10.1186/s40169-016-0121-6
UR  - https://doi.org/10.1186/s40169-016-0121-6
ER  - 

APA

Polansky, H., Itzkovitz, E., & Javaherian, A. (2016). Clinical study of Gene‐Eden‐VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. Clinical and Translational Medicine. https://doi.org/10.1186/s40169-016-0121-6

Source records